Literature DB >> 9123742

Focal therapy for prostate cancer 1996: maximizing outcome.

P R Carroll1, J C Presti, E Small, M Roach.   

Abstract

OBJECTIVES: To summarize improvements in patient selection and the results of focal therapy for the management of localized prostate cancer.
METHODS: A contemporary series of patients managed with wide surgical excision, radiation therapy (three-dimensional conformal radiation, interstitial radiation, and charged-particle or proton therapy), and cryo-therapy were reviewed.
RESULTS: We used preoperative cancer grade, transrectal ultrasound, and serum prostate-specific antigen (PSA) in all patients, and cross-sectional imaging and bone scans in selected patients to allow for reasonably accurate cancer staging and selection of patients most likely to be cured by radical prostatectomy or radiation. In patients with extracapsular extension of prostate cancer, wide surgical excision and achievement of a clear surgical margin had therapeutic value. Newer radiation techniques resulted in a higher likelihood of prostate cancer control than previous techniques. Cryotherapy for patients with stages T1 through 3 prostate cancer was associated with a posttreatment undetectable PSA rate of 48% and a positive biopsy rate of 23%.
CONCLUSIONS: Patients with organ-confined and, therefore, curable prostate cancer can be identified. Well-performed radical prostatectomy, radiation, and cryotherapy are alternative treatments for the management of localized prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9123742     DOI: 10.1016/s0090-4295(97)00174-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  System for MR image-guided prostate interventions: canine study.

Authors:  Robert C Susil; Axel Krieger; J Andrew Derbyshire; Attila Tanacs; Louis L Whitcomb; Gabor Fichtinger; Ergin Atalar
Journal:  Radiology       Date:  2003-09       Impact factor: 11.105

2.  Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  Clin Transl Imaging       Date:  2017-04-10

Review 3.  Advances in MR spectroscopy of the prostate.

Authors:  John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

4.  Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy.

Authors:  Anurag K Singh; Jochen Kruecker; Sheng Xu; Neil Glossop; Peter Guion; Karen Ullman; Peter L Choyke; Bradford J Wood
Journal:  BJU Int       Date:  2007-12-05       Impact factor: 5.588

Review 5.  Multiparametric magnetic resonance imaging in prostate cancer: present and future.

Authors:  John Kurhanewicz; Daniel Vigneron; Peter Carroll; Fergus Coakley
Journal:  Curr Opin Urol       Date:  2008-01       Impact factor: 2.309

Review 6.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.

Authors:  John Kurhanewicz; Mark G Swanson; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

7.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.

Authors:  Jeffrey C Weinreb; Jeffrey D Blume; Fergus V Coakley; Thomas M Wheeler; Jean B Cormack; Christopher K Sotto; Haesun Cho; Akira Kawashima; Clare M Tempany-Afdhal; Katarzyna J Macura; Mark Rosen; Scott R Gerst; John Kurhanewicz
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

8.  Neoadjuvant hormone therapy following treatment with robotic-assisted radical prostatectomy achieved favorable in high-risk prostate cancer.

Authors:  Cheng-Pang Hou; Wei-Chang Lee; Yu-Hsiang Lin; Shao-Ming Chen; Chien-Lun Chen; Phei-Lang Chang; Horng-Heng Juang; Ke-Hung Tsui
Journal:  Onco Targets Ther       Date:  2014-12-17       Impact factor: 4.147

9.  Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy.

Authors:  Taku Naiki; Noriyasu Kawai; Takehiko Okamura; Daisuke Nagata; Yoshiyuki Kojima; Hidetoshi Akita; Takahiro Yasui; Keiichi Tozawa; Kenjiro Kohri
Journal:  BMC Urol       Date:  2012-12-18       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.